Pcas SA
PAR:PCA
Pcas SA
Other
Pcas SA
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pcas SA
PAR:PCA
|
Other
-€19.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-45%
|
CAGR 10-Years
-22%
|
|
|
Sartorius Stedim Biotech SA
PAR:DIM
|
Other
-€154.4m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
-30%
|
|
|
Eurofins-Cerep SA
PAR:ALECR
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pcas SA
Glance View
PCAS SA engages in the development, manufacture, and sale of chemicals. The company is headquartered in Ecully, Auvergne-Rhone-Alpes. The company operates through nine production sites and two main business units, Pharma Synthesis and Fine & Specialty Chemicals. Pharma Synthesis unit specializes in active pharmaceutical ingredients (API), intermediates and building blocks, and early phase services, among others. Fine & Specialty Chemicals unit focuses on custom manufacturing and proprietary products, such as fragrance, flavor ingredients, imaging and microelectronics chemicals. The firm operates several subsidiaries, including Saint-Jean Photochimie, Societe Bearnaise de Synthese, Expansia, PCAS BioMatrix Inc, based in Canada, and PCAS Finland Oy, based in Finland, among others.
See Also
What is Pcas SA's Other?
Other
-19.6m
EUR
Based on the financial report for Jun 30, 2023, Pcas SA's Other amounts to -19.6m EUR.
What is Pcas SA's Other growth rate?
Other CAGR 10Y
-22%
